Skip to main content
Zodiac Ventures Limited logo

Zodiac Ventures Limited — Investor Relations & Filings

Ticker · 503641 ISIN · INE945J01027 LEI · 984500038A14B3768552 BSE.NS Construction
Open in API
Filings indexed 314 across all filing types
Latest filing 2024-08-14 Regulatory Filings
Country IN India
Listing BSE.NS 503641

About Zodiac Ventures Limited

https://zodiacventures.in/

Zodiac Ventures Limited focuses on the development, construction, and management of residential and commercial projects. The company specializes in urban redevelopment initiatives, transforming existing properties into modern residential complexes and commercial spaces. Its operations encompass the entire project lifecycle, from land acquisition and planning to design, execution, and marketing. The firm prioritizes the integration of contemporary architectural designs and functional amenities to cater to urban requirements. By utilizing advanced construction techniques and maintaining rigorous quality standards, the company aims to deliver high-quality infrastructure and living environments. Its portfolio includes a variety of projects ranging from luxury housing to functional office spaces, emphasizing structural durability and aesthetic appeal.

Recent filings

Filing Released Lang Actions
Unaudited Standalone and Consolidated Financial Results for the quarter ending on 30th June 2024 along with limited review reports thereon.
Regulatory Filings
2024-08-14 English
Outcome of Board Meeting dated 14th August 2024.
Regulatory Filings
2024-08-14 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), read with sub-clause (7A) of Clause A in Part A of Schedule ....
Regulatory Filings
2024-08-14 English
Zodiac Ventures Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 ,inter alia, to consider and approve the Unaudited Financial ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the unaudited financial results for the quarter ended June 30, 2024. It is addressed to the stock exchange and references SEBI regulations about disclosure. The document is short (1278 characters) and serves as an announcement of an upcoming event rather than containing actual financial data or results. Therefore, it is not an Interim/Quarterly Report (IR) itself but a notification about the meeting where such results will be approved. This fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and disclosure notice.
2024-08-07 English
Certificate under Regulation 74 (5) of the SEBI (DP) Regulations, 2018 for the quarter ending 30th June 2024.
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June 2024. It is a confirmation certificate related to dematerialisation of securities, confirming compliance with regulatory requirements. The document is addressed to the Bombay Stock Exchange and is signed by the Company Secretary and Compliance Officer. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance certificate rather than a financial report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents that do not fit other specific categories.
2024-07-09 English
Intimation of closure of trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a notice addressed to the Bombay Stock Exchange regarding the closure of the trading window for insiders due to upcoming unaudited quarterly financial results. It references SEBI regulations on insider trading and specifies the trading window closure period around the announcement of quarterly results. The document is short (1379 characters) and is an announcement related to compliance and trading restrictions, not a financial report or earnings release itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-07-01 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.